(Q34492461)

2 August 2017

1 reference

title

Peripheral arterial disease--epidemiological aspects (English)

1 reference

2 August 2017

1 reference

M H Criqui

1

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

6

1 reference

2 August 2017

issue

3 Suppl

1 reference

2 August 2017

page(s)

3-7

1 reference

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Epidemiology of atherosclerotic arterial disease in the lower limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Peripheral arterial disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Diabetes and it's complications in a Swedish county.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Lipid risk factors in patients requiring arterial reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Lipoproteins, atherogenicity, age and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Effects of colestipol-niacin therapy on human femoral atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X0100600I102

10.1177/1358836X0100600I102

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference